The anti-cancer compound CI-1010. designated as (R)-a-([(2-bromoethyl)amino]methyl)-2-nitro-1H-imidazole-l-ethanol monohydrobromide, has a proposed dual mechanism of action due to alkylating and radiosensitizing activities. To assess potential toxicity, adult Wistar rats were treated with a single intravenous injection (0, 50, 100. 150, 225. or 350 mgkg) and necropsied at 4 or 29 days following treatment. In a repeated dose experiment, rats were injected daily (0, 10, 40, or 80 mgkg; 5 doseshvk) for 3 wk and necropsied at the end of week 3 or 7. CI-1010 induced retinal degeneration by 4 days after a single injection of 2225 m g k g or by 3 wk of repeated injections of 2 4 0 mgkg. The locally extensive to diffuse retinal degeneration involved the photoreceptor and outer nuclear layer. The photoreceptor layer was vacuolated and compressed corresponding to ultrastructural evidence of inner segment swelling and outer segment fragmentation. The outer nuclear layer was thinned due to loss of nuclei and contained numerous pyknotic or karyorrhectic nuclci. These nuclear changes were morphologically consistent with apoptosis and many outer nuclear layer nuclei labeled with in siru TdT-mediated dUTP-digoxigenin nick end labeling (Apoptag"). The retinal degeneration was nonreversible, evidenced by increased lesion severity and incidence after CI-1010 was withdrawn for either 25 or 28 days.
INTRODUCTION
A 2-nitroimidazole anticancer compound, CI-1010, has purported dual activity as a radiosensitizer and alkylating agent, similar to a related drug RSU-1069 (4, 14) . In preclinical safety evaluation. CI-1010 treatment resulted in rodent retinotoxicity. The purpose of this study was to characterize more fully CI-1010-induced retinotoxic effects in rats and determine possible lesion reversibility.
Retinal degeneration or retinotoxicity has been associated with various chemical or drug administrations, as reviewed (5). The outer nuclear layer (ONL) and photoreceptor layer (PRL) of the retina are particularly sensitive to retinotoxicity, as exemplified in N-methyl-N-nitrosourea (MNU) toxicity in the hamster (6), rabbit (9), and rat (8). MNU-mediated retinotoxicity is associated with neuronal apoptosis (8) and immunohistochemical evidence of DNA alkylation and adduct formation (9). Similar ONL and PRL degeneration has also been reported following light-induced retinal degeneration in laboratory rodents (1 1).
To characterize more fully CI-10 10-induced retinotoxicity in rats, the retinal lesions in several animal experiments were evaluated by light microscopy, immunohistochemistry, and transmission electron microscopy (TEM). The dose-and time-dependent characteristics of the retinotoxicity were studied, revealing progressive, nonreversible degeneration of the PRL and ONL following CI-1010 treatment. Induction of retinal lesions along with cytotoxicity of other organs in laboratory animals precluded further development of this compound as an anticancer drug.
MATERIALS AND METHODS
Chenticals and Aizinzals. CI-1010, chemically designated as (R)-or-([(2-bromoethyl)amino]methyl)-2-nitro-1H-imidazole-1-ethanol monohydrobromide (Fig. 1) . was supplied by Parke-Davis pharmaceutical delivery systems 'as a lyophilized parenteral dosage formulation. Dosing solutions were prepared each day by reconstituting and diluting drug with 0.9% sodium chloride for injection, USE Dosing solutions were filtered-sterilized through a 0.2-pm filter and administered intravenously in the lateral tail vein using a dose volume of 5 mVkg. The rate of infusion was 0.1 mu20 sec. Random-bred, albino Wistar (Crl:[WI]BR) rats were obtained from Charles River Laboratories. At initiation of dosing, rats were between 6 to 7 wk of age. Rats were housed individually in stainlesssteel cages in a temperature-controlled room with a 12hr light-12-hr dark cycle. Rats were given a standard diet (powdered Purina Certified Rodent Chow 5002) and water ad libitiiin. Rats were observed daily for signs of toxicity and body weights were recorded prior to dosing on day 1, weekly, and prior to scheduled necropsies. All procedures, maintenance, and treatment of rats were in accordance with the principles of humane treatment as Experimental Design. Three separate experiments were conducted to evaluate CI-1010-mediated toxicity in rats. In the first experiment, groups of 10 rats of each sex were administered a single intravenous dose of CI-1010 (vehicle control, 50, 100, 150, 225, or 350 mgkg) . Five animals from each group were necropsied on day 4. The remaining 5 rats in each group were necropsied on day 29 to ascertain the reversibility of drug-related effects. In an auxiliary experiment to provide retinal tissue for ultrastructural evaluation, groups of 5 male rats were administered a single intravenous dose of CI-1010 (vehicle control or 225 mgkg) and necropsied on day 4. To determine effects of repeated doses, groups of 15 rats of each sex were administered intravenous injections of CI-1010 (vehicle control, 10, 40, or 80 mgkg) once/day, 5 consecutive days/wk, for a 3-wk period. Ten rats/sex/dose were necropsied on day 19; remaining 5 rats/sex/dose were necropsied following a 4-wk recovery period without dosing.
-Pathology. In the first and third experiment, both eyes were removed from each rat immediately after euthanasia and fixed for 24 hr in 6.0% glutaraldehyde. Following fixation, intact eyes were embedded in paraffin, sectioned at 4 pm, stained with hematoxylin and eosin, and examined microscopically. In the second experiment, both eyes from each rat were fixed for 24 hr in 6.0% glutaraldehyde, followed by light microscopy processing for one eye and TEM processing for the contralateral eye. For TEM examination, following fixation the eye was transversely bisected and the caudal half of the eye trimmed into approximately 1-mm X 1-mm pieces to provide retinal cross sections. The tissues were then washed in 0.1 M cacodylate buffer, postfixed in 1% osmium tetroxide, embedded in EpodAraldite, sectioned, and examined on a Hitachi H-600 TEM. To verify apoptotic cells histologically, 4-pm-thick sections of eyes from se-lected control and treated rats were processed using the it2 situ apoptosis detection kit (ApoptagB, Oncor, Gaithersburg, MD) as previously described (15). This test detects DNA fragmentation in cells using TdT-mediated dUTP-digoxigenin nick end labeling (TUNEL). The peroxidase label was visualized with the substrate 3,3'-diaminobenzidine (Dako Corporation, Carpinteria, CA).
RESULTS

Histopathology arid Ii~unu~iohistocheriiistry
CI-1010 induced bilateral retinal degeneration 4 days after a single injection of 2225 m g k g or after 3 wk of repeated injections of 240 mgkg (Tables I and 11 ). Male and female rats were similarly affected by CI-1010-induced retinal degeneration. The retinal degeneration was most pronounced in the central area of the retina near the optic nerve; severity gradually diminished peripherally. This locally extensive degeneration involved the PRL and ONL of the retina, characterized by progressive, nonreversible histologic changes. By 4 days after a single injection, the PRL of the central retina was thinner than control retina ( Fig. 2 ) and partially collapsed, consisting of a vacuolated, poorly organized architecture (Fig. 3A) . Occasional vacuolated mononuclear cells, consistent with macrophages, were evident within the PRL area. The ONL was also markedly thinned due to loss of neuron nuclei. Occasional Apoptag-positive pyknotic and karyorrhectic nuclei were evident in remnants of this layer (Fig. 3B) . The peripheral 10-20% of the retinal PRL and ONL were only minimally affected or normal. A transitional zone of retinal degeneration was interposed between the severely affected central retina and minimally affected peripheral retina, characterized by photoreceptor vacuolation and occasional pyknotic nuclei in the ONL. The inner nuclear and ganglion layers were seemingly unaffected. In the first experimental group (2225 mgkg) by day 29, the central retinal PRL and ONL were completely absent, resulting in direct apposition of the inner nuclear layer to the pigmented epithelial cell layer and choroid (Fig. 4) . This severely affected area of the retina abruptly junctioned with normal segments of peripheral retina. By day 29, only rare Apoptag-positive nuclei were evident in the ONL (not shown).
In the repeated-dose experiment, retinal degenerative lesions were evident after 3 wk of treatment in 240-" mgkg animals, similar in character but less severe than described for the single-dose rats. Mild retinal changes in 40-mgkg males (70%) and some females (20%) contrasted with moderately affected retinas in 80-mgkg rats. In the affected 40-mgkg rats, the PRL had prominent vacuolation and thinning of both the outer and inner segments ( Fig 5A) . The ONL had decreased cellularity and contained occasional Apoptag-positive pyknotic or karyorrhectic nuclei (Fig. 5B) . The 80-mgkg rats necropsied after 3 wk of treatment had more severe retinal changes, characterized by marked thinned or absent PRL and mildly to moderately thinned ONL. The retinal lesions were generally more severe after the 4-wk reversal period, and all rats in the 40and 80-mgkg treatment groups were affected (Fig. 6 ). However, there were no Apoptag-positive nuclei in the ONL of 40-mgkg rats at reversal and only occasional Apoptag-positive ONL nuclei in 80mgkg rats (not shown). 
Ultrastri4ctiiral Lesions
Four days following a single intravenous injection of CI-1010 (225 mg/kg), the retina had ultrastructural changes that correlated with the histopathologic findings.
In contrast to control retina (Fig. 7) . the ONL from CI-1010-treated rats contained pyknotic nuclei or nuclear remnants within intact cytoplasmic membranes, consistent with apoptotic cells (Fig. 8) . Empty vacuolated spaces, some of which contained cellular debris, were also in the ONL, presumably resulting from neuron loss. The outer and inner segments of the PRL were markedly thinned. The PRL inner segments were dilated and separated by intersegmental vertical spaces representing loss of individual inner segments. Mitochondria1 integrity was preserved 6.-Retina from a rat, following 3 w k of repeated daily intravenous doses of 80 mgkg CI-1010 and a 4-wk reversal period. Note  the thinned photoreceptor layer and outer nuclear layers. H&E. X312. in most inner segments. Outer segments were often fragmented and decreased in length and number. The pigment epithelium had increased numbers of prominent phagolysosomes, containing compact lamellar disk material.
DISCUSSION
CI-1010 can induce marked ONL and PRL retinal de-.generation following a single intravenous dose. Similar retinal changes were also induced with lower concentrations of drug, administered in repeated doses over a 3wk period. The damage to the retina was confined to the ONL neurons and the associated photoreceptors. The progressive, nonreversible character and anatomic location of the lesion are consistent with other chemical-induced retinal toxicities such as urethan, vigabatrin, and MNU (5). In addition, trimethyltin induces photoreceptor swelling and pyknotic nuclei in the ONL, along with affects on the inner nuclear layer (5). Because of similar morphological characteristics, CI-1010-and MNU-induced retinotoxicities may share a common pathogenesis (8).
Photoreceptor and ONL degeneration has been observed in hamsters (6), rats (8, 9), and rabbits (9) treated with single or repeated doses of MNU. The rapid onset of the lesion within 24-72 hr following treatment is similar to the rapid onset of CI-1010-induced retinal changes by 4 days following treatment. Both MNU and CI-1010 result in dose-related nonreversible, progressive retinal degeneration. Individual ONL neuron cell death due to MNU was consistent with apoptosis, confirmed ultrastructurally and by the Apoptag method (8).
Apoptosis is an active process of cell death that leads to nuclear DNA fragmentation into multiples of 180-200 base pairs, chromosomal condensation, breakdown of intracellular material, and breakup of the cell into several apoptotic bodies (13). Histopathologically, apoptosis is characterized by cell shrinkage, pyknotic and marginated chromatin, karyorrhexis, and eventual budding phenom- enon of cell processes, referred to as apoptotic bodies (7). To verify morphological evidence of apoptosis, either biochemical (13) or immunohistochemical (15) detection' of nuclear DNA fragmentation is utilized. The CI-1010induced outer nuclear cell death was consistent with apoptosis. The positive TUNEL (Apoptag) staining of affected ONL neurons further supports apoptosis as the process of cell death. Similar apoptotic ONL neuron cell death was observed following MNU treatment in rats (€3, and other photoreceptor disease models in rd, rds, and rhodopsin mutant mice (2).
The mechanism of CI-1010-induced ONL neuron apoptosis is not apparent; however, a previous study sug- properties (4, 14) . The critical role of the alkylating moiety of CI-1010 in retinotoxicity was confirmed by a recently completed study in our laboratory. The treatment of mice with CI-1010, following removal of the alkylating moiety, completely prevented the Other mechanisms may also be important in chemicalinduced apoptosis of ONL neurons. For example, transgene-mediated bcl-2 overexpression reduced apoptotic photoreceptor cell death in 3 different mutant mouse models and in constant light-exposed mice (3). Bcl-2 levels in the retina were not monitored in our studies, but it is conceivable that CI-1010 may have had some modulatory effect on the amount of bcl-2 expression by ONL neurons. The ONL and PRL degeneration induced by CI-1010 is also very similar to retinal degeneration resulting from excessive exposure to light (11, 12) . However, a study to examine phototoxicity as a consequence of CI-1010 treatment was conducted, and preliminary data suggest that this is an unlikely pathogenic mechanism (1).
In summary, either single or repeated intravenous ad-ministration of CI-1010 to rats induced a progressive, nonreversible ONL and PRL degeneration characterized by neuronal apoptosis. The mechanism of this selective toxicity may be related to preferential sensitivity of the DNL neurons to alkylating action of CI-1010.
